Literature DB >> 17476087

Is cirrhosis of the liver reversible?

Manoj Kumar1, S K Sarin.   

Abstract

Extensive and persistent hepatic fibrosis has for a long time been considered irreversible. Accumulating evidence suggests that liver fibrosis is reversible and that recovery from cirrhosis may be possible. The application of molecular techniques to models of reversible fibrosis are helping to establish the events and processes that are critical to recovery. The problem consists in identifying and eliminating its cause. Although fibrosis in the liver has little functional significance by itself, its severity derives from associated vascular changes. Disappearance of fibrosis can be accompanied by remodeling of vascular changes. However, depending on its duration, the fibrosis may be irreversible.

Entities:  

Mesh:

Year:  2007        PMID: 17476087     DOI: 10.1007/s12098-007-0067-1

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  47 in total

1.  Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion.

Authors:  H Iwamoto; H Sakai; S Tada; M Nakamuta; H Nawata
Journal:  J Lab Clin Med       Date:  1999-07

Review 2.  Extracellular matrix degradation and the role of hepatic stellate cells.

Authors:  R C Benyon; M J Arthur
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

Review 3.  Liver fibrosis -- from bench to bedside.

Authors:  Scott L Friedman
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

Review 4.  The matrix-degrading metalloproteinases.

Authors:  L M Matrisian
Journal:  Bioessays       Date:  1992-07       Impact factor: 4.345

5.  REVERSIBLE AND IRREVERSIBLE CHANGES IN EXPERIMENTAL CIRRHOSIS.

Authors:  P S QUINN; J HIGGINSON
Journal:  Am J Pathol       Date:  1965-09       Impact factor: 4.307

Review 6.  Mechanisms of hepatic fibrosis.

Authors:  R C Benyon; M J Arthur
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-07       Impact factor: 2.839

Review 7.  Reversal of hepatic fibrosis -- fact or fantasy?

Authors:  Scott L Friedman; Meena B Bansal
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

8.  Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment.

Authors:  J F Dufour; R DeLellis; M M Kaplan
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

9.  Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel.

Authors:  Q Mohamed-Ali; E Doehring-Schwerdtfeger; I M Abdel-Rahim; J Schlake; R Kardorff; D Franke; C Kaiser; M Elsheikh; M Abdalla; P Schafer
Journal:  Am J Trop Med Hyg       Date:  1991-04       Impact factor: 2.345

10.  Disruption of epithelial cell-matrix interactions induces apoptosis.

Authors:  S M Frisch; H Francis
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

View more
  11 in total

1.  Alleviation of Dimethylnitrosamine-Induced Liver Injury and Fibrosis by Supplementation of Anabasis articulata Extract in Rats.

Authors:  Azza M Mohamed; Mohga S Abdalla; Maha Z Rizk; El-Sayed M E Mahdy; Abdel-Razik H Farrag; Fatma S El-Sharabasy; Hanan F Aly; Mohamed R Mohamed
Journal:  Indian J Clin Biochem       Date:  2013-06-14

2.  Therapy with bone marrow cells reduces liver alterations in mice chronically infected by Schistosoma mansoni.

Authors:  Sheilla Andrade Oliveira; Bruno-Solano-Freitas Souza; Carla-Adriana Guimaraes-Ferreira; Elton-Sa Barreto; Siane-Campos Souza; Luiz-Antonio-Rodrigues Freitas; Ricardo Ribeiro-Dos-Santos; Milena-Botelho-Pereira Soares
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

3.  Bone marrow stromal cells control the growth of hepatic stellate cells in vitro.

Authors:  Lijun Shi; Guozhong Li; Jinghua Wang; Bo Sun; Liming Yang; Guangyou Wang; Dandan Wang; Lili Mu; Hui Chen; Lianhong Jin; Nikolaos Kostulas; Hulun Li
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

4.  Autoimmune hepatitis unmasked by nimesulide.

Authors:  Rita Magalhães; Margarida Fonseca; Ilídio Brandão; Sofia Caridade
Journal:  BMJ Case Rep       Date:  2016-01-20

5.  Expression of Septin4 in human hepatic stellate cells LX-2 stimulated by LPS.

Authors:  Xiaolei Sun; Yanan Yang; Dandan Zhu; Hongyan Qian; Yinong Duan; Xingxin He; Xijuan Gu; Wei Sun; Ying Zhu
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

6.  Reactive oxygen species released from hypoxic hepatocytes regulates MMP-2 expression in hepatic stellate cells.

Authors:  Jing Li; Renhua Fan; Susu Zhao; Leilei Liu; Shanshan Guo; Nan Wu; Wandong Zhang; Pingsheng Chen
Journal:  Int J Mol Sci       Date:  2011-04-07       Impact factor: 5.923

7.  Inhibition of liver fibrosis using vitamin A-coupled liposomes to deliver matrix metalloproteinase-2 siRNA in vitro.

Authors:  Yiping Li; Feng Liu; Fengan Ding; Pingsheng Chen; Meng Tang
Journal:  Mol Med Rep       Date:  2015-05-25       Impact factor: 2.952

8.  Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats.

Authors:  Xu-Jia Chen; Wen-Jing Liu; Meng-Liang Wen; Hong Liang; Shao-Mei Wu; Yun-Zhen Zhu; Jiang-Yuan Zhao; Xiang-Qian Dong; Ming-Gang Li; Li Bian; Cheng-Gang Zou; Lan-Qing Ma
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

9.  Effects of emodin, a plant-derived anthraquinone, on TGF-β1-induced cardiac fibroblast activation and function.

Authors:  Wayne Carver; Ethan Fix; Charity Fix; Daping Fan; Mrinmay Chakrabarti; Mohamad Azhar
Journal:  J Cell Physiol       Date:  2021-05-27       Impact factor: 6.513

10.  Spleen dynamic contrast-enhanced magnetic resonance imaging as a new method for staging liver fibrosis in a piglet model.

Authors:  Li Zhou; Tian-wu Chen; Xiao-ming Zhang; Cheng-jun Li; Zhen-feng Yang; Nan-lin Zeng; Li-ying Wang; Ting Li; Dan Wang; Jie Li; Chun-ping Li; Li Li; Xian-yong Xie
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.